Michael Mensinger
Fortuna: 4 M $ al 31/08/2026
Fortuna: 4 M $ al 31/08/2026
Mr. Michael R.
Mensinger is a Chief Product Officer at Beta Bionics, Inc. Mr. Mensinger was previously employed as a Chief Technology Officer by Companion Medical, Inc. and an Engineering Manager by DexCom, Inc. He received his undergraduate degree from the University of Delaware.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BETA BIONICS, INC. 0,39 % | 16/09/2026 | 177.390 ( 0,39 % ) | 4 M $ | 31/08/2026 |
BETA BIONICS, INC. -.--% | 29/01/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BETA BIONICS, INC. | Corporate Officer/Principal | 01/08/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Director Técnico/Científico/I+D | 01/08/2023 |
| DEXCOM, INC. | Corporate Officer/Principal | 01/04/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.